Financials
- Market Capitalization 2.29 B
- Employee 890
- Founded 1996
- CEO Matthew M. Mannelly
- Website www.prestigebrands.com
- Headquarter New York, United States
- FIGI BBG000QM0RZ4
- Industry 药品制造—专业与仿制药
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
15.16
市销率
2.79
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1779 | SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 47.73 USD | +2.29% | -5.86% | +10.05% | -11.61% | 2.77 B USD | ||
| 1842 | RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.13 USD | -9.20% | -19.97% | -69.46% | -69.17% | 2.54 B USD | ||
| 1989 | HCM HUTCHMED (China) Limited - American Depositary Shares | 11.59 USD | +3.02% | +3.67% | +11.55% | -32.81% | 2.02 B USD | ||
| 2057 | ANIP ANI Pharmaceuticals, Inc. - Common Stock | 80.82 USD | +0.34% | -4.00% | -2.63% | -14.59% | 1.84 B USD |